Every pharma collateral goes through a review process designed to answer two questions. Is the content medically accurate? Is it regulatory compliant?
Both are essential. But there is a third question that almost no review process asks: when the MR closes this visual aid and walks out, what will the doctor remember?
In most cases, the honest answer is nothing.
Not because the content was wrong. Because there was no single message strong enough to stick.
The 90-second problem
A typical visual aid carries six to eight key messages. The product manager wants the efficacy story. Medical affairs wants the safety narrative represented. The marketing head wants competitive differentiation highlighted. Everyone has a legitimate reason for inclusion.
The MR gets about 90 seconds with the doctor. Sometimes less. Six messages in 90 seconds means each message gets roughly 15 seconds of attention. That is not a conversation. That is a ticker tape.
The visual aid passes internal review because the review is built to check accuracy and compliance. It is not built to check memorability. Nobody in the approval chain is asking whether this collateral will survive the ten seconds after the MR leaves the room.
Why internal approval and external impact diverge
This is why brand managers who have been in the industry long enough all arrive at the same uncomfortable realisation. The collateral that satisfies everyone internally is often the one that reaches no one externally.
The brands that break through this pattern do something that sounds simple but is organisationally very difficult. They choose one message. Not the most important three. One. One clinical insight. One patient outcome. One differentiator. Everything else in the collateral supports that single message or gets cut.
The discipline of subtraction
This requires the brand manager to have a conversation that most people in pharma avoid. It means going back to a stakeholder and saying their point will not appear on the visual aid. Not because it is wrong, but because it dilutes the one thing the doctor needs to remember.
The discipline of subtraction is the most undervalued skill in pharma marketing. Addition feels productive. You are covering more ground, addressing more inputs, showing thoroughness. Subtraction feels like a risk. What if the doctor asks about the thing we left out?
A simple test before print
There is a simple test worth applying before any visual aid goes to print. Cover every page except one. If you could only show the doctor a single page, which one would it be? Now look at that page. Does it carry a single, clear, memorable message? Is that message supported by the visual hierarchy? Would the doctor remember it five minutes later?
If you cannot answer that confidently, the collateral is not ready. Not because it is non-compliant. Because it will not be remembered.